Paid Clinical Trials in Winchester, VA
As of August 2026, 43 paid clinical trials are recruiting in Winchester, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Winchester offers studies at sites including Shenandoah Oncology for conditions such as Obesity, Paroxysmal Atrial Fibrillation, Breast Cancer, Breast Neoplasms. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Winchester
Trials by drug in Winchester
Filter results
Newly added in Winchester
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
41 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
REPRESENT-PF Registry
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Intramedullary Calcium Sulfate Antibiotic Depot
Single Versus Dual Implant Fixation of Distal Femur Fractures
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Transitional Care Program to Improve Risk Factors in Stroke Survivors
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Top Research Study Locations in Winchester
Researchers run research studies in Winchester, VA at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Shenandoah Oncology | Breast Cancer, CRC (Colorectal Cancer), Extensive-stage Small-cell Lung Cancer | 7 |
| Selma Medical Associates | Obesity, Overweight, Cardiovascular Disease | 6 |
| Shenandoah Oncology, P.C. | Advanced Non-Small-Cell Lung Cancer, Breast Neoplasms, EGFR P-Loop and Alpha C-Helix Compressing | 4 |
| Valley Health System | Paroxysmal Atrial Fibrillation, Open Tibia Fracture, Osteomyelitis Tibia | 4 |
| Shenandoah Oncology PC | Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma | 3 |
| Valley Health | Articular Fractures, Open tíbia Fracture, Osteomyelitis Tibia | 3 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 2 |
| Selma Medical Associates, Winchester | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure | 2 |
| Amherst Family Practice, P.C. | Lyme Disease | 1 |
| Ep0162 50726 | Stereotypical Prolonged Seizures | 1 |
| Ep0165 50726 | Stereotypical Prolonged Seizures | 1 |
| Local Institution - 0528 | Non-Small Cell Lung Cancer | 1 |
| Shenandoah Oncology P.C. | Non Small Cell Lung Cancer (Squamous or Non Squamous), Stage 4 NSCLC | 1 |
| VCU Massey Cancer Center Affiliate Valley Health | Cutaneous Melanoma, Stage II | 1 |
| Valley Health / Winchester Medical Center | Pancreatic Neoplasm | 1 |
| Valley Health Surgery Center | Lumbar Spinal Stenosis | 1 |
| Winchester Cardiology and Vascular Medicine | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Winchester Medical Center | Atrial Fibrillation | 1 |
Active & Upcoming Studies in Winchester (2026)
Recruiting trials in Winchester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (16 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer · Phase 3 · AbbVie
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- REPRESENT-PF Registry · Vivek Reddy
Diabetes & metabolic (6 active studies)
- A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight · Phase 3 · Novo Nordisk A/S
- AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
Neurology & pain (2 active studies)
- A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy · Phase 2, Phase 3 · Jazz Pharmaceuticals
- Transitional Care Program to Improve Risk Factors in Stroke Survivors · Syntrillo, Inc
Vaccines (1 active study)
Common conditions studied in Winchester
- Obesity (5 active studies)
- Paroxysmal Atrial Fibrillation (3 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
- Diabetes Mellitus, Type 2 (2 active studies)
- Heart Failure (2 active studies)
Leading research sponsors in Winchester
- Novo Nordisk A/S
- Wake Forest University Health Sciences
- Bristol-Myers Squibb
- BioNTech SE
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Winchester?
There are approximately 43 recruiting clinical trials in Winchester, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Winchester pay participants?
Most recruiting trials in Winchester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Winchester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Winchester?
The most common conditions under active study in Winchester include Obesity (5), Paroxysmal Atrial Fibrillation (3), Breast Cancer (2), Breast Neoplasms (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Winchester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Winchester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Winchester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Winchester?
Recruiting research sites in Winchester include Shenandoah Oncology, Selma Medical Associates, Shenandoah Oncology, P.C., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Winchester right now?
The largest active categories in Winchester are Cancer & tumors (16), Cardiovascular (10), Diabetes & metabolic (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.